Human papilloma virus, vaccination and social justice: An analysis of a canadian school-based vaccine program

Public Health Ethics

Volumn 6, Issue 1, 2013, Pages 11-20

  Thompson, Alison ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CANCER; CANADA; CANCER MORTALITY; CONDYLOMA ACUMINATUM; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ETHICAL THEORY; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HERD IMMUNITY; HUMAN; MALE HOMOSEXUAL; MASS IMMUNIZATION; META ANALYSIS (TOPIC); PAPILLOMAVIRUS INFECTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCHOOL HEALTH SERVICE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL ISOLATION; SOCIAL JUSTICE; SOCIAL STATUS; UTERINE CERVIX CANCER; VACCINATION; WELLBEING;

EID: 84875621164     PISSN: 17549973     EISSN: 17549981     Source Type: Journal    
DOI: 10.1093/phe/pht010     Document Type: Conference Paper

References (53)

1. Booth, C. M., Li, G., Zhang-Salomons, J. and Mackillop, W. J. (2010). The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer, 116, 4160-4167.
2. Castellsagué, X. (2008). Natural History and Epidemiology of HPV Infection and Cervical Cancer. Gynecologic Oncology, 110, S4-S7.
3. CBC Radio. The Current (2007). The Ontario govern-ment is taking a shot at saving lives. Aired 3 August 2007. Available at http://www.cbc.ca/ thecurrent/2007/200708/20070803.html [accessed 19 May 2009].
4. Crowcroft, N. S., Hamid, J. S., Deeks, S. and Frank, J. (2012). Human Papilloma Virus Vaccination Programs Reduce Health Inequity in Most Scenarios: A Simulation Study. BMC Public Health, 12, 935.
5. CSDH. (2008). Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Geneva: World Health Organization.
6. Donnelly, T. T., Mc Kellin, W., Hislop, G. and Long, B. (2009). Socioeconomic Influences on Vietnamese-Canadian Women's Breast and Cervical Cancer Prevention Practices: A Social Determinant's Perspective. Social Work in Public Health, 24, 454-476.
7. Elit, L., Krzyzanowska, M., Saskin, R., Barbera, L., Razzaq, A., Lofters, A., Yeritsyan, N. and Bierman, A. (2012). Sociodemographic Factors Associated with Cervical Cancer Screening and Follow-up of Abnormal Results. Canadian Family Physician, 58, e22-e31.
8. Faden, R. and Powers, M. (2000). Inequalities in Health, Inequalities in Health Care: Four Generations of Discussion about Justice and Cost-Effectiveness Analysis. Kennedy Institute of Ethics Journal, 10, 109-127.
9. Gillespie, K. (2007). Girls to get Cancer Vaccine. The Toronto Star, 2 August 2007.
10. Herring, D. A., Waldram, J. B. and Young, T. K. (2006). Aboriginal Health in Canada: Historical, Cultural, and Epidemiological Perspectives. 2nd edn. Toronto: University of Toronto Press, Scholarly Publishing Division.
11. Hislop, T. G., Teh, C., Lai, A., Ralston, J. D., Shu, J. and Taylor, V. M. (2004). Pap Screening and Knowledge of Risk Factors for Cervical Cancer in Chinese Women in British Columbia, Canada. Ethnicity & Health, 9, 267-281.
12. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011). Global cancer statistics. Cancer Journal for Clinicians, 61, 69-90.
13. Kahn, J. A., Brown, D. R., Ding, L., Widdice, L. E., Shew, M. L., Glynn, S. and Bernstein, D. I. (2012). Vaccine-type Human Papillomavirus and Evidence of Herd Protection after Vaccine Introduction. Pediatrics, 130, e249-e256.
14. Khadilkar, A. and Chen, Y. (2012). Rate of Cervical Cancer Screening Associated with Immigration Status and Number of Years Since Immigration in Ontario, Canada. Journal of Immigrant and Minor Health.
15. Kim, J. J. (2010). Targeted Human Papillomavirus Vaccination of Men Who Have Sex with Men in the USA: A Cost-Effectiveness Modelling Analysis. The Lancet Infectious Diseases, 10, 845-852.
16. Klein, N. P. et al. (2012). Safetyof Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females. Archives of Pediatrics & Adolescent Medicine, 166, 1140-1148.
17. Legislative Services Branch. (2012). Consolidated Federal Laws of Canada, Canada Health Act, available from: http://laws-lois.justice.gc.ca/eng/ acts/C-6/page-1.html [accessed 1 November 2012].
18. Lexchin, J., Arya, N. and Singh, S. (2010). Gardasil, the New HPV Vaccine: The Right Product, the Right Time? A Commentary. Healthcare Policy, 5, 26-36.
19. Lippmann, A. (1999). Choice as a Risk to Women's Health. Health, Risk and Society, 1, 281-291.
20. Lippman, A. (2000). Geneticization and the Canadian Biotechnology Strategy: The Marketing of Women's Health. In: Miller, F., Weir, L., Mykitiuk, R., Lee, P., Sherwin, S. and Tudiver, S. (eds), The Gender of Genetic Futures: The Canadian Biotechnology Strategy, Women and Health. Toronto: York University, pp. 32-41.
21. Lippman, A., Melnychuk, R., Shimmin, C. and Boscoe, M. (2007). Human Papillomavirus, Vaccines and Women's Health: Questions and Cautions. Canadian Medical Association Journal, 177, 484-487.
22. Lofters, A. K., Hwang, S. W., Moineddin, R. and Glazier, R. H. (2010). Cervical Cancer Screening among Urban Immigrants by Region of Origin: A Population-Based Cohort Study. Preventive Medicine, 51, 509-516.
23. Mackillop, W. J., Zhang-Salomons, J., Groome, P. A., Paszat, L. and Holowaty, E. (1997). Socioeconomic status and cancer survival in Ontario. Journal of Clinical Oncology, 15, 1680-1689.
24. Mc Carthy, A. M., Dumanovsky, T., Visvanathan, K., Kahn, A. R. and Schymura, M. J. (2010). Racial/ ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes & Control, 21, 1645-1655.
25. Mc Donald, J. T. and Kennedy, S. (2007). Cervical Cancer Screening by Immigrant and Minority Women in Canada. Journal of Immigrant and Minor Health, 9, 323-334.
26. NACI. (2007). National Advisory Committee on Immunization Statement on human papillomavirus vaccine. Canada Communicable Disease Report, 33, 1-31, Available at www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07pdf/acs33-02.pdf [accessed 9 September 2012].
27. Ng, E., Wilkins, R., Fung, M. F. K. and Berthelot, J. -M. (2004). Cervical Cancer Mortality by Neighbour-hood Income in Urban Canada from 1971 to 1996. Canadian Medical Association Journal, 170, 1545-1549.
28. Nussbaum, M. (2001). Women and Human Development: The Capabilities Approach. Cambridge: Cambridge University Press.
29. Nussbaum, M. and Sen, A. (1993). The Quality of Life. Oxford: Clarendon Press.
30. Olowokure, B., Spencer, N. J., Hawker, J. I., Blair, I. and Smith, R. L. (2003). Changing Socioeconomic Risk Factors for Invasive H. influenzae Disease after the Introduction of Conjugate Vaccine. Journal of Infection, 46, 46-48.
31. Panagiotopoulos, T. and Georgakopoulou, T. (2004). Epidemiology of Rubella and Congenital Rubella Syndrome in Greece, 1994-2003. Eurosurveillance, 9, 17-19.
32. Parikh, S., Brennan, P. and Boffetta, P. (2003). Meta-Analysis of Social Inequality and the Risk of Cervical Cancer. International Journal of Cancer, 105, 687-691.
33. Petersen, A. and Lupton, D. (1997). The New Public Health: Health and Self in the Age of Risk. 1st edn. London: Sage.
34. PHAC (2006). Management and Treatment of Specific Infections: Genital Human Papillomavirus Infections. In: Canadian Guidelines on Sexually Transmitted Infections. Ottawa: PHAC, Available from: http://www.phac-aspc.gc.ca/std-mts/ sti-its/cgsti-ldcits/section-5-5-eng.php [accessed 9 September 2012.
35. PIDAC-I. (2012). Recommendations for Human Papillomavirus Vaccination. Ontario: Public Health Ontario.
36. Powers, M. and Faden, R. (2008). Social Justice: The Moral Foundations of Public Health and Health Policy. 2nd edn. USA: Oxford University Press.
37. Rabin, R. (2006). A New Vaccine for Girls: But Should it be Compulsory? New York Times, 18 July 2006.
38. Rambout, L. et al. (2007). Prophylactic Vaccination Against Human Papillomavirus Infection and Disease in Women: A Systematic Review of Randomized Controlled Trials. Canadian Medical Association Journal, 177, 469-479.
39. Redwood-Campbell, L., Fowler, N., Laryea, S., Howard, M. and Kaczorowski, J. (2011). 'Before You Teach Me, I Cannot Know': Immigrant Women's Barriers and Enablers with Regard to Cervical Cancer Screening among Different Ethnolinguistic Groups in Canada. Canadian Journal of Public Health, 102, 230-234.
40. Romanow, R. (2002). Buildingon Values: The Future of Health Care in Canada. Ottawa: The Romanow Commission Report.
41. Sama. (2010). Concerns around the human papilloma virus vaccine. Indian Journal of Medical Ethics, 7, 38-41. Available from http://www.ijme.in/pdfs/ 181de38.pdf [accessed 9 September 2012].
42. Sen, A. (1979). Equality of What?, Tanner Lecture on Human Values. Stanford University, 22 May 1979.
43. Seto, K., Marra, F., Raymakers, A. and Marra, C. A. (2012). The Cost-Effectiveness of Human Papillomavirus Vaccines: A Systematic Review. Drugs, 72, 715-743.
44. Simard, E. P., Fedewa, S., Ma, J., Siegel, R. and Jemal, A. (2012). Widening socioeconomic disparities in cer-vical cancer mortality among women in 26 states, 1993-2007. Cancer, 118, 5110-5116.
45. Singh, G. K., Williams, S. D., Siahpush, M. and Mulhollen, A. (2007). Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part I-All Cancers and Lung Cancer and Part II-Colorectal, Prostate, Breast, and Cervical Cancers. Journal of Cancer Epidemiology, pp. 1051-1057.
46. Talaga, T. (2007). Lobbyists Boosted Vaccine Program. The Toronto Star, 16 August 2007.
47. Tully, S. P., Anonychuk, A. M., Sanchez, D. M., Galvani, A. P. and Bauch, C. T. (2012). Time for Change? An Economic Evaluation of Integrated Cervical Screening and HPV Immunization Programs in Canada. Vaccine, 30, 425-435.
48. Ueda, K., Kawachi, I. and Tsukuma, H. (2006). Cervical and corpus cancer survival disparities by socioeco-nomic status in a metropolitan area of Japan. Cancer Science, 97, 283-291.
49. Vasilevska, M., Ross, S. A., Gesink, D. and Fisman, D. N. (2012). Relative risk ofcervical cancer in indigen-ous women in Australia, Canada, New Zealand, and the United States: A systematic review and meta-analysis. Journal of Public Health Policy, 33, 148-164.
50. Verweij, M. and Dawson, A. (2012). Risk, Risk Groups and Population Health. Public Health Ethics, 5, 213-215.
51. Wilson, S. E., Harris, T., Sethi, P., Fediurek, J., Macdonald, L. and Deeks, S. L. (2013). Coverage from Ontario, Canada s school-based HPV vaccine program: The first three years. Vaccine, 31, 757-762.
52. Zimet, G. D. (2006). Understanding and Overcoming Barriers to Human Papillomavirus Vaccine Acceptance. Current Opinion in Obstetrics and Gynecology, 18, S23-S28.
53. Zimmerman, R. K. (2006). Ethical Analysis of HPV Vaccine Policy Options. Vaccine, 24, 4812-4820.